3 267

Cited 6 times in

Laparoscopic Fenestration Versus Percutaneous Catheter Drainage for Lymphocele Treatment After Kidney Transplantation

Authors
 H.S. Lee  ;  D.J. Joo  ;  K.H. Huh  ;  M.S. Kim  ;  S.I. Kim  ;  Y.S. Kim  ;  W.J. Lee 
Citation
 TRANSPLANTATION PROCEEDINGS, Vol.45(4) : 1667-1670, 2013 
Journal Title
 TRANSPLANTATION PROCEEDINGS 
ISSN
 0041-1345 
Issue Date
2013
MeSH
Adult ; Catheters, Indwelling* ; Drainage ; Female ; Humans ; Kidney Transplantation* ; Laparoscopy* ; Lymphocele/surgery* ; Male ; Middle Aged ; Treatment Outcome ; Young Adult
Keywords
Adult ; Catheters, Indwelling* ; Drainage ; Female ; Humans ; Kidney Transplantation* ; Laparoscopy* ; Lymphocele/surgery* ; Male ; Middle Aged ; Treatment Outcome ; Young Adult
Abstract
BACKGROUND: Laparoscopic fenestration (LF) and percutaneous catheter drainage (PCD) are widely accepted treatments for symptomatic lymphoceles. The aim of this study was to review the results and compare the outcomes of LF with those of PCD. PATIENTS AND METHODS: Among 1363 patients who underwent kidney transplantation at our institute between 1999 and 2011, 35 (2.5%) developed symptomatic lymphoceles. Among them, 7 were treated by LF after PCD; 10, LF only, and 18 PCD only. The patients were divided into 2 groups based upon the treatment method: LF (n = 17) and PCD-only groups (n = 18). RESULTS: No intergroup differences in age, gender, diabetes prevalence, retransplant rate, delayed graft function, or serum creatinine was observed at 7 days after the treatment. However, acute rejection episodes and sirolimus use were more frequent among the LF group (P = .028). Furthermore, median drainage on the first day was significantly greater in the LF versus PCD group. After catheter insertion, the PCD group showed a significant decrease in drainage on the following day, but no decrease was observed in the LF group. CONCLUSIONS: LF is a safe treatment for symptomatic lymphocele. LF should be held in reserve for treatment failures after PCD. LF seems to be a more reasonable first-line treatment for symptomatic lymphoceles in patients at high risk for graft dysfunction.
Full Text
http://www.sciencedirect.com/science/article/pii/S0041134512013887
DOI
10.1016/j.transproceed.2012.11.019
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Myoung Soo(김명수) ORCID logo https://orcid.org/0000-0002-8975-8381
Kim, Soon Il(김순일) ORCID logo https://orcid.org/0000-0002-0783-7538
Kim, Yu Seun(김유선) ORCID logo https://orcid.org/0000-0002-5105-1567
Lee, Woo Jung(이우정) ORCID logo https://orcid.org/0000-0001-9273-261X
Lee, Hyung Soon(이형순)
Joo, Dong Jin(주동진) ORCID logo https://orcid.org/0000-0001-8405-1531
Huh, Kyu Ha(허규하) ORCID logo https://orcid.org/0000-0003-1364-6989
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/87032
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse